A Review on Cervical Cancer Vaccination
| dc.contributor.author | Emmanuel Ifeanyi Obeagu | |
| dc.contributor.author | Yakubu Sunday Bot | |
| dc.contributor.author | Getrude Uzoma Obeagu | |
| dc.contributor.author | Adekemi Linda Adejare | |
| dc.date.accessioned | 2024-07-29T12:28:25Z | |
| dc.date.available | 2024-07-29T12:28:25Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Cervical cancer is the fourth most common cancer in women worldwide. Approximately 90% of deaths from cervical cancer occur in low- and middle-income countries, but mortality varies 18-fold worldwide. The introduction of human papillomavirus (HPV) vaccines in many countries has significantly reduced HPV specific infection rates. Several studies have investigated the HPV vaccine intake [5-6] and found that the intake was low Lack of knowledge and passive attitudes have been reported to be one of the reasons for this low intake. Women's knowledge of HPV infection and vaccination was found to be low. HPV vaccination coverage is low, which is related to urban living and HPV awareness. | |
| dc.description.sponsorship | Kampala International University, Uganda | |
| dc.identifier.issn | 2992-4081 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12493/14529 | |
| dc.language.iso | en | |
| dc.publisher | Eurasian Experiment Journal of Public Health | |
| dc.title | A Review on Cervical Cancer Vaccination | |
| dc.type | Article |